August 4, 2023
Taiho Pharmaceutical said on August 3 that it has received US regulatory approval for a combination therapy of its cancer drug Lonsurf (trifluridine + tipiracil) paired with bevacizumab for the treatment of certain patients with metastatic colorectal cancer (mCRC). The...read more